News & Press Releases: Breaking News

2019 Commercialization Signature Series Meeting Report Now Available

Wednesday, July 10, 2019  
Share |

For the third annual ISCT Commercialization Signature Series, ISCT Patron and Partner member companies gathered in Miami in January for discussion on the theme of ‘Patients First: Achieving Global CGT Adoption’.

The team at Cell & Gene Therapy Insights captured all the meeting highlights including keynote speaker Reni Benjamin (Raymond James), session 1 speakers  Dan Shoemaker (Fate Therapeutics), Luca Alberici (MolMed), Amy DuRoss (Vineti) and Simon Ellison  (World Courier) who discussed challenges in getting the product to the patient, followed by Gerhard Bauer (UC Davis), Richard Maziarz (Oregon Health & Science University), Mehrdad Abedi (UC Davis) and Peter Olagunju (bluebird bio) on strategies to overcoming adoption barriers. 

Read more.

© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy